PubMed Health⌕ Search

Biomedical subjects

C Villaseca

Publications and source records attributed to C Villaseca.

2 recordsLinked to original sources

[Genetic variation of MSX1 has a sexual dimorphism in non syndromic cleft palate in the Chilean population].

BACKGROUND: Recent studies in mice have demonstrated that the Msx-1 homebox gene is implicated in cleft palate. Thus, it has been suggested that its human homologue, MSX1 (HOX-7), located in chromosome 4 could be involved in the etiology of non syndromic cleft lip palate. AIM: To study the linkage between non syndromic cleft palate and variations of MSX1 gene. PATIENTS AND METHODS: Seventy three patients with non syndromic cleft lip palate (34 simplex and 37 multiplex), 127 unaffected relatives of the cases (61 relatives of simplex cases and 66 relatives of multiplex cases) and 77 controls were studied. DNA was extracted from leukocytes and the intragenic microsatellite sequence was amplified by PCR. RESULTS: A polymorphism of four alleles was observed, 1 (175 bp), 2 (173 bp), 3 (171 bp) and 4 (169 bp). Alleles 2 and 4 showed a joint variation in males with multiplex cleft lip palate and in their respective unaffected male relatives, that was significant when compared with male controls. Instead, the joint variation of alleles 1 and 4 of unaffected female relatives had significant differences with female controls. Females with multiplex cleft lip palate differed from female controls only in allele 1. CONCLUSIONS: These results support the hypothesis of a genetic heterogeneity in the etiology of non syndromic cleft lip palate.

Alleles↗

[Gene therapy and its applications].

Gene therapy consists in the introduction of genes in cells of the human organism. It allows the treatment of not only monogenic diseases (those in which one gene is altered, such as rare enzymatic diseases), but also of diseases in which there is an acquired gene alteration such as AIDS and cancer, and diseases in which several genes and the environment interact, such as diabetes and coronary artery disease. In the few years of development of this therapy several clinical trials have been approved, that, along with experiment of this therapy several clinical trials have been approved, that, along with experimental research, are offering promising results. In this new field of modern medicine, specially in experiments related to genetic manipulation of germinal cells, ethical aspects have great importance.

Acquired Immunodeficiency Syndrome↗